Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00548
|
|||||
| Drug Name |
Ethacrynic acid
|
|||||
| Synonyms |
(2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid; (2,3-Dichloro-4-(2-methylenebutyryl)phenoxy)acetic acid; (2,3-Dichloro-4-[2-methylenebutyryl]phenoxy)acetic acid; (4-(2-Methylenebutyryl)-2,3-dichlorophenoxy)acetic acid; 2,3-Dichloro-4(2-methylene-butyryl)phenoxy] acetic acid; 2,3-Dichloro-4-(2-methylenebutyl)phenoxyacetic acid; 2,3-Dichloro-4-(2-methylenebutyryl)phenoxy acetic acid; 2,3-Dichloro-4-(2-methylenebutyryl)phenoxyacetic acid; 2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid; Acide etacrynique; Acide etacrynique [INN-French]; Acido etacrinico; Acido etacrinico [INN-Spanish]; Acidum etacrynicum; Acidum etacrynicum [INN-Latin]; Crinuryl; E0526; Edecril; Edecrin; Edecrin (TN); Edecrina; Endecril; Etacrinic acid; Etacrynic Acid; Etacrynic acid (JP15/INN); Etakrinic acid; Ethacrinic acid; Ethacrinique (acide); Ethacryinic Acid; Ethacrynate; Ethacrynic Acid, Sodium Salt; Ethacrynic acid (USP); Ethacrynic acid [USAN:BAN]; Hidromedin; Hydromedin; Kyselina 4-(2-(1-butenyl)karbonyl)-2,3-dichlorfenoxyoctova; Kyselina 4-(2-(1-butenyl)karbonyl)-2,3-dichlorfenoxyoctova [Czech]; Kyselina ethakrynova; Kyselina ethakrynova [Czech]; MK 595; MK-595; Methylenebutyryl phenoxyacetic acid; Methylenebutyrylphenoxyacetic acid; Mingit; Otacril; Reomax; Taladren; Uregit; [2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy]acetic acid; [2,3-Dichloro-4-(2-methylenebutyryl)phenoxy]acetic acid;[2,3-dichloro-4-(2-methylenebutanoyl)phenoxy]acetic acid; [2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid; [4-(2-Methylenebutyryl)-2,3-dichlorophenoxy]acetic acid
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | High blood pressure [ICD11: BA00] | Approved | [1] | |||
| Therapeutic Class |
Diuretics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C13H12Cl2O4
|
|||||
| Canonical SMILES |
CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)O)Cl)Cl
|
|||||
| InChI |
InChI=1S/C13H12Cl2O4/c1-3-7(2)13(18)8-4-5-9(12(15)11(8)14)19-6-10(16)17/h4-5H,2-3,6H2,1H3,(H,16,17)
|
|||||
| InChIKey |
AVOLMBLBETYQHX-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 58-54-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 303.13 | Topological Polar Surface Area | 63.6 | ||
| Heavy Atom Count | 19 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
3.8
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10321631
, 11112144
, 11336075
, 11361314
, 11363707
, 11366269
, 11368831
, 11371330
, 11374346
, 11376993
, 11446250
, 11462286
, 11466287
, 11467407
, 11483790
, 11486033
, 11487913
, 11490241
, 11492359
, 11494627
, 122995
, 14776240
, 17389016
, 24894577
, 26611737
, 26680116
, 26706137
, 26746983
, 26746984
, 29222417
, 46392033
, 46394202
, 46507562
, 47662347
, 47736552
, 47959820
, 47959821
, 47959822
, 48110508
, 48185057
, 48423385
, 491575
, 5208062
, 7847379
, 7887267
, 798369
, 8149337
, 8152080
, 834701
, 855762
|
|||||
| ChEBI ID |
ChEBI:4876
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | MRP1 | Transporter Info | Multidrug resistance-associated protein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Ethacrynic acid was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Inhibition of the multidrug resistance protein 1 (MRP1) by peptidomimetic glutathione-conjugate analogs. Mol Pharmacol. 2002 Nov;62(5):1160-6. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.